Electronic health record (EHR) was hailed as a major step towards making healthcare more transparent and accountable. All the developed nations digitised their health records which were meant to be safe, secure and could be accessed on demand. This was intended to benefit all stakeholders. However, the jury is still out if the EHR has been worth it. There have been incidences of data breaches despite cybersecurity checks and of manipulation compromising clinicians’ integrity and patients’ safety. EHRs have also been blamed for doctor burnout in overloading them with a largely avoidable administrative burden. The lack of interoperability amongst various EHR software systems is creating obstacles in seamless workflow. Artificial intelligence is now being used to overcome deficiencies of the EHR. Emerging data from real-world usage of EHR is providing useful inputs which would be helpful in making it a better system. This review critically appraises the current status and issues with the EHR and provides an overview of the key innovations which are being implemented to make the system more efficient for health care providers leading to a reduction in their administrative burden.

The chikungunya virus (CHIKV) infection epidemic has emerged as a significant public health concern in the last 10–15 years, especially in Asian and south American countries. However, with ever-expanding tourism and migration, cases have now been reported in north America and Europe. CHIKV infection predominantly causes musculoskeletal symptoms with a chronic polyarthritis which may resemble autoimmune inflammatory arthritis. CHIKV infection should always be suspected in a returning traveller presenting with fever, skin rash and arthralgia. Though first reported in the last century, a series of epidemics since 2004 have substantially improved our knowledge. There has also been a significant increase in our understanding of the immunopathogenesis of chikungunya infection. This knowledge is being used in the development of new treatment strategies and preventive measures. In this narrative review, we discuss some of the recent advances in the epidemiology, immunopathogenesis, and management of CHIKV arthritis.